Trial Profile
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo- Controlled Study to Assess the Efficacy and Safety of EN3285 for the Prevention or Delay to Onset of Severe Oral Mucositis in Patients With Head and Neck Cancer Receiving Chemoradiotherapy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Mucositis
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 28 May 2014 New trial record